Pharmacogenetics in Neuroblastoma: What Can Already Be Clinically Implemented and What Is Coming Next?
International Journal Of Molecular Sciences
Olivera, Gladys G GG; Urtasun, Andrea A; Sendra, Luis L; Aliño, Salvador F SF; Yáñez, Yania Y; Segura, Vanessa V; Gargallo, Pablo P; Berlanga, Pablo P; Castel, Victoria V; Cañete, Adela A; Herrero, María José MJ
Akt1 genetic variants confer increased susceptibility to thyroid cancer.
Endocrine Connections
Crezee, Thomas T; Petrulea, Mirela M; Piciu, Doina D; Jaeger, Martin M; Smit, Jan W A JWA; Plantinga, Theo S TS; Georgescu, Carmen E CE; Netea-Maier, Romana R
Association of polymorphisms of PTEN, AKT1, PI3K, AR, and AMACR genes in patients with prostate cancer.
Genetics And Molecular Biology
Nóbrega, Monyse de M; Cilião, Heloisa Lizotti HL; Souza, Marilesia Ferreira de MF; Souza, Milene Roldão de MR; Serpeloni, Juliana Mara JM; Fuganti, Paulo Emilio PE; Cólus, Ilce Mara de Syllos IMS
Association between polymorphisms in PRNCR1 and risk of colorectal cancer in the Saudi population.
Plos One
AlMutairi, Mohammad M; Parine, Narasimha Reddy NR; Shaik, Jilani Purusottapatnam JP; Aldhaian, Sooad S; Azzam, Nahla A NA; Aljebreen, Abdulrahman M AM; Alharbi, Othman O; Almadi, Majid A MA; Al-Balbeesi, Amal O AO; Alanazi, Mohammad M
Genetic variations in the PI3K/PTEN/AKT/mTOR pathway predict tumor response and disease-free survival in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy and radical surgery.
Genetic variations in the PI3K-PTEN-AKT-mTOR pathway are associated with distant metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
Scientific Reports
Guo, Qiaojuan Q; Lu, Tianzhu T; Chen, Yan Y; Su, Ying Y; Zheng, Yuhong Y; Chen, Zeng Z; Chen, Chao C; Lin, Shaojun S; Pan, Jianji J; Yuan, Xianglin X
Roles of genetic variants in the PI3K and RAS/RAF pathways in susceptibility to endometrial cancer and clinical outcomes.
Journal Of Cancer Research And Clinical Oncology
Wang, Li-E LE; Ma, Hongxia H; Hale, Katherine S KS; Yin, Ming M; Meyer, Larissa A LA; Liu, Hongliang H; Li, Jie J; Lu, Karen H KH; Hennessy, Bryan T BT; Li, Xuesong X; Spitz, Margaret R MR; Wei, Qingyi Q; Mills, Gordon B GB
PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy.
Lung Cancer (Amsterdam, Netherlands)
Pu, Xia X; Hildebrandt, Michelle A T MA; Lu, Charles C; Lin, Jie J; Stewart, David J DJ; Ye, Yuanqing Y; Gu, Jian J; Spitz, Margaret R MR; Wu, Xifeng X
Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.
Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology
Hildebrandt, Michelle A T MA; Yang, Hushan H; Hung, Mien-Chie MC; Izzo, Julie G JG; Huang, Maosheng M; Lin, Jie J; Ajani, Jaffer A JA; Wu, Xifeng X